Pelthos Therapeutics Inc.
AMEX:PTHSBiotechnology
-$0.37 today
- Market cap
- $63.32M
- Beta
- 3.13
- P/E (TTM)
- -0.7
- EPS (TTM)
- -$15.58
Volume 0.01M
Average 0.04M
Balance Sheet
Inspect the capital base behind the business.
Assets
$130.40M
FY 2025 · Annual
+9424.0% YoYLiabilities
$91.52M
FY 2025 · Annual
+2141.3% YoYEquity
$38.88M
FY 2025 · Annual
Balance Sheet
Balance Sheet
Assets, liabilities & equity
| Cash & Equivalents | $32.2M |
| Receivables | $11.7M |
| Inventory | $23.4M |
| Other Current | $1.7M |
| Total Current Assets | $69.1M |
| PP&E (Net) | $12.5M |
| Goodwill | $24.7M |
| Intangible Assets | $38.4M |
| Other Non-current | $711.0K |
| Total Non-current Assets | $76.3M |
| Total Assets | $145.4M |
Analysis
Selected assets total $145.4M for Latest. The largest visible component is Intangible Assets at $38.4M, about 26.4% of the tab total. Use the mix to judge balance sheet concentration, liquidity, leverage, and how much of book value is supported by tangible operating assets.
Competitors
Peer companies in the same sector
Recent Filings
Recent regulatory filings
| Filing | Description | Date | |
|---|---|---|---|
| 8-K | Current report | May 28, 2026 | |
| 4 | Statement of changes in beneficial ownership | May 26, 2026 | |
| 144 | Notice of proposed sale of securities | May 22, 2026 | |
| 8-K | Current report | May 21, 2026 | |
| 4 | Statement of changes in beneficial ownership | May 18, 2026 |
How much cash does PTHS have?
Pelthos Therapeutics Inc. (PTHS) reported $18.02M in cash and equivalents in fiscal 2025.
How much debt does PTHS carry?
Pelthos Therapeutics Inc. (PTHS) reported $34.83M of total debt, with net debt of $16.80M.
Continue the stock analysis
Jump to another research area for this company.